Literature DB >> 15131009

Vascular endothelial growth factor receptor-2-induced initial endothelial cell migration depends on the presence of the urokinase receptor.

Gerald W Prager1, Johannes M Breuss, Stefan Steurer, Damla Olcaydu, Judit Mihaly, Patrick M Brunner, Hannes Stockinger, Bernd R Binder.   

Abstract

The angiogenic response of endothelial cells initiated by different growth factors is accompanied by assembly of cell surface-bound proteolytic machinery as a prerequisite for focal invasion. We have shown previously how the vascular endothelial growth factor (VEGF) initiates proteolysis by activation of pro-urokinase (pro-PA) via the VEGF receptor-2 (VEGFR-2). We now show that the cell surface receptor of the uPA-system, the urokinase receptor (uPAR), is redistributed to focal adhesions at the leading edge of endothelial cells in response to VEGF. VEGF165 and VEGF-E, both interacting with VEGFR-2, but not PlGF exclusively stimulating VEGFR-1, induce within minutes internalization of uPAR via an LDL receptor-like molecule, dependent on generation of active uPA and the presence of plasminogen activator inhibitor-1 (PAI-1). uPAR seems to play a pivotal role in VEGFR-2-induced endothelial cell migration because cleavage of surface uPAR impaired the migratory response of endothelial cells toward VEGF-E, but not toward PlGF.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15131009     DOI: 10.1161/01.RES.0000131498.36194.6b

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  30 in total

1.  Design, synthesis, biochemical studies, cellular characterization, and structure-based computational studies of small molecules targeting the urokinase receptor.

Authors:  Fang Wang; W Eric Knabe; Liwei Li; Inha Jo; Timmy Mani; Hartmut Roehm; Kyungsoo Oh; Jing Li; May Khanna; Samy O Meroueh
Journal:  Bioorg Med Chem       Date:  2012-06-12       Impact factor: 3.641

2.  VEGF-induced endothelial cell migration requires urokinase receptor (uPAR)-dependent integrin redistribution.

Authors:  Revu Ann Alexander; Gerald W Prager; Judit Mihaly-Bison; Pavel Uhrin; Stefan Sunzenauer; Bernd R Binder; Gerhard J Schütz; Michael Freissmuth; Johannes M Breuss
Journal:  Cardiovasc Res       Date:  2012-01-26       Impact factor: 10.787

3.  FOXM1c promotes pancreatic cancer epithelial-to-mesenchymal transition and metastasis via upregulation of expression of the urokinase plasminogen activator system.

Authors:  Chen Huang; Dacheng Xie; Jiujie Cui; Qi Li; Yong Gao; Keping Xie
Journal:  Clin Cancer Res       Date:  2014-01-22       Impact factor: 12.531

4.  Small-molecule inhibition of the uPAR·uPA interaction: synthesis, biochemical, cellular, in vivo pharmacokinetics and efficacy studies in breast cancer metastasis.

Authors:  Timmy Mani; Fang Wang; William Eric Knabe; Anthony L Sinn; May Khanna; Inha Jo; George E Sandusky; George W Sledge; David R Jones; Rajesh Khanna; Karen E Pollok; Samy O Meroueh
Journal:  Bioorg Med Chem       Date:  2013-01-09       Impact factor: 3.641

5.  FOXM1 and its oncogenic signaling in pancreatic cancer pathogenesis.

Authors:  Chen Huang; Jiawei Du; Keping Xie
Journal:  Biochim Biophys Acta       Date:  2014-01-11

6.  Protective, repairing and fibrinolytic effects of rivaroxaban on vascular endothelium.

Authors:  Ezequiel Álvarez; Beatriz Paradela-Dobarro; Sergio Raposeiras-Roubín; José Ramón González-Juanatey
Journal:  Br J Clin Pharmacol       Date:  2017-10-25       Impact factor: 4.335

7.  Dissecting mannose 6-phosphate-insulin-like growth factor 2 receptor complexes that control activation and uptake of plasminogen in cells.

Authors:  Vladimir Leksa; Karin Pfisterer; Gabriela Ondrovičová; Brigitte Binder; Silvia Lakatošová; Clemens Donner; Herbert B Schiller; Alexander Zwirzitz; Katarína Mrvová; Vladimir Pevala; Eva Kutejová; Hannes Stockinger
Journal:  J Biol Chem       Date:  2012-05-21       Impact factor: 5.157

8.  Urokinase-type Plasminogen Activator (uPA) Promotes Angiogenesis by Attenuating Proline-rich Homeodomain Protein (PRH) Transcription Factor Activity and De-repressing Vascular Endothelial Growth Factor (VEGF) Receptor Expression.

Authors:  Victoria Stepanova; Padma-Sheela Jayaraman; Sergei V Zaitsev; Tatiana Lebedeva; Khalil Bdeir; Rachael Kershaw; Kelci R Holman; Yelena V Parfyonova; Ekaterina V Semina; Irina B Beloglazova; Vsevolod A Tkachuk; Douglas B Cines
Journal:  J Biol Chem       Date:  2016-05-04       Impact factor: 5.157

9.  uPAR: a modulator of VEGF-induced angiogenesis.

Authors:  Pavel Uhrin; Johannes M Breuss
Journal:  Cell Adh Migr       Date:  2012-10-17       Impact factor: 3.405

Review 10.  VEGF-initiated angiogenesis and the uPA/uPAR system.

Authors:  Johannes M Breuss; Pavel Uhrin
Journal:  Cell Adh Migr       Date:  2012-10-17       Impact factor: 3.405

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.